LENZ Therapeutics Inc (NASDAQ: LENZ) — Healthcare · Share Price, Chart & Market Data
About: LENZ Therapeutics, Inc. operates as a commercial pharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States. Its product candidates include VIZZ and LNZ101 for the treatment of presbyopia in adults. LENZ Therapeutics, Inc. was formerly known as Presbyopia Therapies, Inc. and changed its name to LENZ Therapeutics, Inc. in June 2021. The company was founded in 2013 and is headquartered in Solana Beach, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $9.64 (+0.63%)
LENZLENZ Therapeutics Inc
Loading watchlist status…
Trade LENZ now
LENZ Therapeutics Inc share price
LENZ price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
17 Apr, 7:13 am GMT+0
LENZ price performance
6,284%
5D
-17,888%
1M
-39,75%
YTD
-58,196%
1Y
LENZ price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
17 Apr, 7:13 am GMT+0
LENZ details
LENZ Market Signals